Scinovex
articleTop 1% cited

Quantifying heterogeneity in a meta‐analysis

Statistics in Medicine · 2002 · Vol. 21(11) · pp. 1539–1558
Julian P. T. HigginsSimon G. Thompson

Abstract

The extent of heterogeneity in a meta-analysis partly determines the difficulty in drawing overall conclusions. This extent may be measured by estimating a between-study variance, but interpretation is then specific to a particular treatment effect metric. A test for the existence of heterogeneity exists, but depends on the number of studies in the meta-analysis. We develop measures of the impact of heterogeneity on a meta-analysis, from mathematical criteria, that are independent of the number of studies and the treatment effect metric. We derive and propose three suitable statistics: H is the square root of the chi2 heterogeneity statistic divided by its degrees of freedom; R is the ratio of the standard error of the underlying mean from a random effects meta-analysis to the standard error of a fixed effect meta-analytic estimate, and I2 is a transformation of (H) that describes the proportion of total variation in study estimates that is due to heterogeneity. We discuss interpretation, interval estimates and other properties of these measures and examine them in five example data sets showing different amounts of heterogeneity. We conclude that H and I2, which can usually be calculated for published meta-analyses, are particularly useful summaries of the impact of heterogeneity. One or both should be presented in published meta-analyses in preference to the test for heterogeneity.

Meta-analysis and systematic reviewsHemodynamic Monitoring and TherapyStatistical Methods in Clinical TrialsMeta-analysisStudy heterogeneityStatisticsStatisticRandom effects modelMetric (unit)Spatial heterogeneityEconometricsMathematicsVariance (accounting)

MeSH terms

AlbuminsClinical Trials as TopicCognition DisordersCytidine Diphosphate CholineFibrosisFracture FixationHip FracturesHumansResuscitationSarcomaStatistics as TopicMeta-Analysis as TopicSclerotherapyChemotherapy, Adjuvant

Funding

  • Medical Research Council
Citations
36,106
FWCI
156.39
field-weighted impact
References
30
Percentile
100%
vs. same field & year
Citations per year
Cited by
Anti-diabetes role of ginger
Journal of Medicinal Plants Studies · 2022 · 0 citations
Socioeconomic Inequality and Caries
Journal of Dental Research · 2014 · 740 citations
The diagnostic odds ratio: a single indicator of test performance
Journal of Clinical Epidemiology · 2003 · 2,272 citations
Quantifying Publication Bias in Meta-Analysis
Biometrics · 2017 · 1,574 citations
Effectiveness of brief alcohol interventions in primary care populations
Cochrane Database of Systematic Reviews · 2018 · 1,662 citations
References
RE: “ESTIMABILITY AND ESTIMATION IN CASE-REFERENT STUDIES”
American Journal of Epidemiology · 1977 · 1,557 citations
Pharmacological interventions for somatoform disorders in adults
Cochrane Database of Systematic Reviews · 2014 · 11,357 citations
Explaining heterogeneity in meta-analysis: a comparison of methods
Statistics in Medicine · 1999 · 1,721 citations
The Combination of Estimates from Different Experiments
Biometrics · 1954 · 5,313 citations
ESTIMABILITY AND ESTIMATION IN CASE-REFERENT STUDIES
American Journal of Epidemiology · 1976 · 1,329 citations
Handbook of Mathematical Functions with Formulas, Graphs, and Mathematical Tables
Mathematics of Computation · 1965 · 18,919 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.